PeerJ PrePrints , http://dx.doi.org/10.7287/peerj.preprints.579v1 2 Nov 2014
International Journal of Drug Policy 24 (2013) e91-98
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002462 November 28, 2017
Rueda S, et al. BMJ Open 2016;6:e011453. doi:10.1136/bmjopen-2016-011453
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002514 March 1, 2018
PLOS ONE | www.plosone.org 1
December 2013 | Volume 8 | Issue 12 | e82027
PLOS ONE | DOI:10.1371/journal.pone.0172392 February 16, 2017
PLOS ONE | https://doi.org/10.1371/journal.pone.0183180 October 9, 2017
PLOS ONE | https://doi.org/10.1371/journal.pone.0196380 May 15, 2018
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with HIV (PLHIV). Our objective was to calculate the incidence, to describe the main cau...ses and to identify the predictive factors of the first change of ARV treatment in Senegal.
more
Integrated Management of Adolescent and Adult Illness (IMAI)
July 2008
Previous studies have highlighted a range of individual determinants associated with HIV testing but few have assessed the role of contextual factors. The objective of this paper is to examine the influence of both individual and community-level determinants of HIV testing uptake in Burkina Faso.
1PEP GUIDELINES | 2019 EDITION. The prevalence of both HIV and Hepatitis B is high in South Africa therefore there is a significant risk of acquiring these infections following exposure to infected material. Studies suggest that post- exposure prophylaxis (PEP) with highly active antiretroviral trea...tment (HAART) is highly effective in preventing HIV infection if taken correctly for the full recommended duration of 28 days, and that prophylaxis with Hepatitis B immunoglobulin and vaccination may prevent Hepatitis B infection if given soon after exposure. This update of the Western Cape guidelines for management of potentially infectious exposures is based on current evidence and guidelines issued by the WHO, NDoH and the SA HIV Clinicians Society. The key aim is to promote successful completion of the recommended ART regimen in the 28 day period of therapy, as well as prevent infection with Hepatitis B
more